美国转基因三文鱼商业化的启示

Autor: DaYuan Wang
Rok vydání: 2016
Předmět:
Zdroj: Chinese Science Bulletin. 61:289-295
ISSN: 0023-074X
DOI: 10.1360/n972015-01395
Popis: The US Food and Drug Administration (FDA) announced on November 16, 2015 that the genetically modified AquAdvantage Salmon is as safe to eat as non-GMO salmons. This means that the genetically modified fish has finally been approved by the sole authority in this field-FDA-in the United States, and can now be legally marketed as food. It is worth noting that the world’s first institute to obtain a genetically modified fish was the Institute of Hydrobiology, the Chinese Academy of Sciences, whose research remains, even now, at the forefront of the researches in the world, but has not yet been commercialized. This is a fact that deserves out reflections. The current Chinese legislation on transgenic plants, animals and foods can no longer account for the emergence of new biotechnologies, especially the gene-edit technology. In July 2015, the US President’s Office of Science and Technology Policy sent a memorandum entitled “Modernizing the Regulatory System for Biotechnology Products” to the Department of Agriculture, FDA, and the Environmental Protection Agency, requiring them to produce a draft regulation in one year for further discussion. How to amend Chinese regulations and policies concerning China’s biotechnology industry needs the combined efforts of scientists, legal experts, and government officials, who should conduct comprehensive discussions of and make decisions on the industrialization of biotechnology.
Databáze: OpenAIRE